1. Overall survival is longer for patients receiving a combination of lenvatinib plus pembrolizumab as compared with chemotherapy treatment alone...

1. Programmed death-ligand 1 copy number loss was identified as an independent risk factor for the progression of the disease...

1. Canadian patients receive subcutaneous administration of medications and/or fluids more frequently than patients from the United States. 2. Length...

1. Localized prostate cancer mortality remains similar between groups receiving prostatectomy, radiotherapy, or active monitoring. 2. About 25% of men...

1. Mandated and available paid-sick-leave resulted in increased colorectal and breast cancer screening rates 2. Screening rates for both colorectal...

1. The proportion of patients receiving serious illness conversations (SICs) was increased in the intervention groups. 2. Patients receiving SICs...

1. Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with cetuximab. 2. Median progression-free survival...

1. Fewer instances of clinically insignificant prostate cancer were identified in an experimental group receiving prostate MRI and targeted biopsy...

1. Patients receiving autologous tumour lysate-loaded dendritic cell vaccine (DCVax-L) had a 20% relative reduction in death risk. 2. DCVax-L...

1. Median overall survival was longer in patients receiving steroid-only treatment for adverse events associated with immune response. 2. Patients...